Radioactive iodine-125 (I-125) is the most widely used radioactive sealed source for
interstitial permanent brachytherapy (BT). BT has the exceptional ability to deliver extremely …

Radiation therapy along with chemotherapy and surgery are the three main treatment
modalities used in oncology. The main disadvantage of radiotherapy is the fact that it affects …

Background Radiotherapy enhances innate and adaptive anti-tumour immunity. It is unclear
whether this effect may be harnessed by combining immunotherapy with radiotherapy …

Background Stereotactic body radiotherapy (SBRT) is becoming increasingly used in
treating localized prostate cancer (PCa), with evidence showing similar toxicity and efficacy …

Background Few studies have evaluated mental health disorders comprehensively among
patients with prostate cancer on long-term follow-up. The primary aim of our study was to …

Background To determine whether combining brachytherapy with immunotherapy is safe in
prostate cancer (PCa) and provides synergistic effects, we performed a Phase I/II trial on the …

Simple Summary Life expectancy in Western countries and East Asian countries has
incremented over the past decades, resulting in a rapidly aging world, while in general …

Purpose To evaluate the feasibility of prostatic artery embolization in patients with low-risk
prostate cancer (PC) under active surveillance (AS). Methods This monocentric prospective …

The treatment of prostate cancer is partly guided by patient preferences. Radical
prostatectomy and radiation therapy are the standard radical therapies for localized disease …

Radiotherapy in combination with androgen deprivation therapy (ADT) is a standard
treatment option for men with localized and locally advanced prostate cancer. However …